Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere Shortening | 2 | 2021 | 34 | 0.770 |
Why?
|
| Sirtuins | 1 | 2019 | 19 | 0.600 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 877 | 0.470 |
Why?
|
| Mitochondria | 4 | 2017 | 731 | 0.400 |
Why?
|
| Telomere | 3 | 2021 | 209 | 0.400 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 192 | 0.350 |
Why?
|
| Telomerase | 3 | 2019 | 153 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 727 | 0.290 |
Why?
|
| Chromatin | 2 | 2022 | 478 | 0.290 |
Why?
|
| Aging | 2 | 2012 | 1190 | 0.280 |
Why?
|
| Telomere Homeostasis | 2 | 2019 | 45 | 0.240 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 63 | 0.200 |
Why?
|
| Collagen Type VI | 1 | 2021 | 7 | 0.180 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 28 | 0.180 |
Why?
|
| Protein Subunits | 1 | 2021 | 162 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 134 | 0.170 |
Why?
|
| Cullin Proteins | 1 | 2020 | 13 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 207 | 0.160 |
Why?
|
| Hematopoiesis | 1 | 2021 | 207 | 0.160 |
Why?
|
| Fibrosis | 1 | 2021 | 398 | 0.160 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 4 | 0.150 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 34 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 193 | 0.150 |
Why?
|
| Claudins | 1 | 2018 | 30 | 0.150 |
Why?
|
| Muscle Proteins | 2 | 2018 | 398 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 56 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2905 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 235 | 0.140 |
Why?
|
| Mitosis | 1 | 2018 | 190 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2011 | 165 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 828 | 0.140 |
Why?
|
| Glioblastoma | 2 | 2012 | 332 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 236 | 0.130 |
Why?
|
| Animals | 14 | 2021 | 33184 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 648 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 443 | 0.130 |
Why?
|
| Cell Movement | 2 | 2018 | 850 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 55 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2019 | 769 | 0.130 |
Why?
|
| Mice | 11 | 2021 | 17629 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4512 | 0.120 |
Why?
|
| Signal Transduction | 7 | 2021 | 4482 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 239 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1937 | 0.110 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 54 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 713 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 534 | 0.100 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 1886 | 0.100 |
Why?
|
| Genes, Essential | 1 | 2012 | 43 | 0.090 |
Why?
|
| Genes, myc | 2 | 2022 | 95 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 1763 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2017 | 755 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3716 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 979 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2012 | 511 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 189 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 124 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 380 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 372 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2011 | 433 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 200 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2399 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2020 | 2344 | 0.070 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 20 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 516 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 606 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 68 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 12 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 365 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2018 | 708 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 404 | 0.070 |
Why?
|
| Carcinogens | 1 | 2008 | 128 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1370 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 495 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 126518 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2010 | 1857 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2585 | 0.060 |
Why?
|
| Stem Cells | 1 | 2010 | 683 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 14 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1205 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 5947 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1225 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3503 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 57 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1813 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 234 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2021 | 123 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2021 | 33 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 48 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 170 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 133 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 107 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 880 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2020 | 130 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 168 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 420 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 178 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 477 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 25 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 27 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 685 | 0.040 |
Why?
|
| Phenotype | 3 | 2017 | 4311 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 67 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 63 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 319 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 633 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 349 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 190 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 714 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 554 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1495 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 351 | 0.030 |
Why?
|
| DNA Damage | 2 | 2011 | 498 | 0.030 |
Why?
|
| Male | 3 | 2019 | 62339 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Proteogenomics | 1 | 2018 | 107 | 0.030 |
Why?
|
| Female | 3 | 2019 | 68161 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1662 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 123 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1378 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3388 | 0.030 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 267 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2017 | 240 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1538 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 563 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 762 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 2 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 28 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 57 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2012 | 24 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 1758 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1031 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 144 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1011 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 361 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 198 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 2011 | 17 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 97 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2012 | 61 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 36 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 63 | 0.020 |
Why?
|
| Chloroquine | 1 | 2011 | 30 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2010 | 2 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 109 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 149 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 35 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 540 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 253 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 658 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 61 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 415 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 238 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 119 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 436 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 581 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 565 | 0.020 |
Why?
|
| Smell | 1 | 2010 | 122 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2010 | 130 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 495 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 344 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 452 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 156 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 678 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 51 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 677 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 76 | 0.020 |
Why?
|
| Epidermis | 1 | 2008 | 63 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 169 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 479 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1559 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 1573 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3261 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 3039 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 2852 | 0.010 |
Why?
|